Trading Concept
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
Trading Concept
No Result
View All Result
Home Trading News

Former Theranos patient testifies that blood test at Walgreens came back with false positive for HIV

by
November 18, 2021
in Trading News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

RELATED POSTS

Berenberg downgrades FedEx, cuts price target on rising inflation risks

JPMorgan says investors are too worried about Apple, sees 40% rebound before year-end

Elizabeth Holmes, founder of Theranos Inc., left, arrives at federal court in San Jose, California, U.S., on Wednesday, Sept. 22, 2021.

Davie Paul Morris | Bloomberg | Getty Images

SAN JOSE, CALIF. – Erin Tompkins, who got her blood drawn from a Theranos device at a Walgreens in Arizona, said the test misdiagnosed her as having an HIV antibody, sending her into a panic.

“I was quite emotional at the time,” Tompkins told jurors on Wednesday in the criminal trial of Theranos founder Elizabeth Holmes.

Tompkins, a witness to the prosecution and the second patient to testify, said she first read about Theranos in Forbes. She later learned more about the blood-testing company on Facebook from a friend who was looking for affordable health-care options.

Holmes is facing 12 counts of wire fraud and conspiracy to commit wire fraud in what federal prosecutors allege is a decade-long scheme to dupe investors and patients about her company’s blood-testing capabilities. Holmes has pleaded not guilty.

Tompkins said she was persuaded by Theranos’ low prices. She told jurors that she asked her doctor to order her a blood test in May 2015. She paid for the test out of pocket because she didn’t have insurance.

“When you decided to go to Theranos for blood testing were you counting on accurate blood test results?” John Bostic, an assistant U.S. attorney, asked of Tompkins.

“Absolutely,” Tompkins said.

“Between cost and accuracy which of those is more important to you?” Bostic asked.

“Well, I think accuracy is most important any time you’re having a medical procedure but cost was a very close second,” Tompkins replied.

Tompkins’ test indicated she had “abnormal results” and pointed to HIV antibodies. Tomkins testified that she had never been diagnosed with HIV or AIDS nor did she ever have any symptoms.

Shortly after getting the results, Tompkins said she called Theranos to speak to someone in the laboratory. Tompkins said she reached a customer service representative who told her she “couldn’t transfer me and that was about it.”

“At any time did you speak to a scientist or a medical professional at Theranos?” Bostic asked.

“No,” Tompkins said.

Three months after the test, Tompkins went to a different clinic to get screened again for HIV. The results came back negative. She was tested again for HIV in August 2021, and received another negative result.

Tompkins’ testimony continues on Thursday.

WATCH: Elizabeth Holmes said she was the ‘ultimate decision maker’ at Theranos

ShareTweetPin

Related Posts

Berenberg downgrades FedEx, cuts price target on rising inflation risks

by
July 1, 2022
0

Shares of FedEx are a "show me story" until the company can prove it can deliver on their turn-around strategy,...

JPMorgan says investors are too worried about Apple, sees 40% rebound before year-end

by
July 1, 2022
0

Apple may be dealing with lower consumer demand and growing FX challenges, but JPMorgan is "not as worried" about the...

The Dow just booked its worst first half since 1962. What history says about the path ahead.

by
July 1, 2022
0

This bear has claws. A bear market that began on the first trading day of 2022 drove down the S&P...

Apple Ex-Corporate Law Chief Admits Years of Insider Trading

by
July 1, 2022
0

TipRanks Future Winners? 3 Stock Giants Jim Cramer Bets On If there’s one common theme connecting the market’s experts, it’s...

JetBlue extends tender offer date for Spirit Airlines to July 29

by
July 1, 2022
0

A photo of a Spirit Airlines jet coming in for a landing in Las Vegas on 25 May 2020. JetBlue...

Next Post

Macy's earnings top estimates as company lures in new customers, hikes outlook

Alibaba misses expectations as earnings plunge 38% in the September quarter

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:



By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

MOST VIEWED

  • Forget Tesla — this auto stock is the one to buy right now, analyst says

    0 shares
    Share 0 Tweet 0
  • WHO says Covid vaccine booster programs will prolong pandemic

    0 shares
    Share 0 Tweet 0
  • Spin or Split? AT&T Has a Big Decision to Make on Discovery Stake.

    0 shares
    Share 0 Tweet 0
  • Here’s how Carl Icahn is positioning for a possible recession in America

    0 shares
    Share 0 Tweet 0
  • Some lawmakers and their families are betting thousands of dollars on crypto

    0 shares
    Share 0 Tweet 0
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
All rights reserved by tradingconcept.net
No Result
View All Result
  • Email Whitelisting
  • Home
  • Privacy Policy

All rights reserved by www.tradingconcept.net